Hatib, Jalula L.
HRN: 06-61-58 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
CEFUROXIME 1.5GM (VIAL)
09/30/2025
10/06/2025
IV
1.5
Q8
Prophylaxis
Waiting Final Action